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Abstract: Lactobacillus paracasei K5 is a lactic acid bacteria (LAB) strain that has been isolated from
dairy products. Previous studies have established its probiotic potential in a series of in vitro tests,
including molecular characterization, safety profiling, and tolerability of the gastrointestinal tract
conditions. To characterize its beneficial actions on the host, we have shown previously that L. paracasei
K5 adheres to Caco-2 cells and exerts anti-proliferative effects through the induction of apoptosis.
In the present study, we focused on the immunomodulatory potential of this strain. We employed the
dorsal-air-pouch mouse model of inflammation and recorded an eight-fold increase in the recruitment
of immune cells in mice treated with the probiotic strain, compared to the control group. Analysis
of the exudates revealed significant changes in the expression of pro-inflammatory mediators on
site. Treatment of Caco-2 cells with L. paracasei K5 induced significant upregulation of cytokines
interleukin-1α (IL-1α), IL-1β, IL-6, tumor necrosis factor-alpha (TNF-α), the chemokine C-X-C motif
ligand 2 (CXCL2), and the inflammation markers soluble intercellular adhesion molecule (sICAM)
and metallopeptidase inhibitor-1 (TIMP-1). Transient induction of the Toll-like receptors (TLRs) 2,
4, 6, and 9 expression levels was recorded by real-time PCR analysis. These results highlight the
immunomodulatory potential of this strain and further support its probiotic character.
Keywords: probiotics; cytokines; air pouch; immunomodulation; Toll-like receptors
1. Introduction
Probiotics are defined as viable microorganisms that, when administered in adequate quantities,
confer a health benefit on the host [1]. Numerous studies have provided compelling evidence for
the health promoting effects of probiotics on the host, including alleviation of the symptoms of
irritable bowel syndrome [2]; relief of Clostridium difficile–associated diarrhea [3]; management of
allergic disorders, such as atopic dermatitis (eczema) and allergic rhinitis [4]; and reduction of serum
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cholesterol [5]. Several Lactobacillus species have been employed as probiotics, including Lactobacillus
casei, L. plantarum, and L. rhamnosus. Still, the probiotic properties typically vary and differ among the
various strains; thus, the identification and in-depth characterization of probiotic strains is of high
importance prior to their utilization in the food industry.
The health-promoting effects of the probiotic species are exerted through several cellular and
molecular mechanisms, such as adhesion to the intestinal epithelium [6], competition with invading
pathogens [7], reinforcement of the epithelial barrier, and production of antimicrobial molecules [8].
Moreover, a plethora of in vitro and in vivo studies has shown that probiotic bacteria can stimulate
different cell populations of the immune system and modulate the responses [9]. For instance, probiotics
can interact with the intestinal mucosa and residing immune cells, such as lymphocytes, macrophages,
or dendritic cells, and trigger the production of cytokines, chemokines, or immunoglobins [10].
The immunomodulatory activities of probiotic bacteria are mainly mediated through the activation of
TLRs. TLRs are expressed in a plethora of cells, including the intestinal epithelial cells (IEC) that line
the gastrointestinal tract [11]. Post-stimulation TLRs trigger cellular cascades, leading to the activation
of key signaling molecules, such as Nuclear Factor-kappa B (NF-κB) and p38 Mitogen Activated Protein
Kinase (MAPK), that orchestrate inflammatory and adaptive immunity responses [11].
Lactobacillus paracasei K5 is a lactic acid bacteria (LAB) strain that has been isolated from dairy
products [12]. Its identification and molecular characterization were performed by Multiplex PCR
and Random Amplification of Polymorphic DNA (RAPD) analysis, while its probiotic potential was
established through a series of in vitro tests that simulate the acidic conditions of the stomach and
evaluate its safety for consumption [12]. Furthermore, its utilization as a starter culture in the production
of novel functional foods and drinks, such as soft white cheese, pomegranate juice, and sourdough
bread has been reported before [13–15]. Additionally, we demonstrated recently that L. paracasei K5
was able to adhere efficiently to Caco-2 colon cancer cells and inhibit their proliferation in a time- and
dose-dependent manner. The observed antiproliferative effect was elicited mainly through induction
of apoptosis by altering the expression of specific apoptosis-related genes [16].
Here, we investigated the immunomodulatory properties of L. paracasei K5, to further explore and
validate its probiotic character. By employing the dorsal-air-pouch model of inflammation, we studied
the recruitment of immune cells in mice treated with the probiotic strain. The expression levels
of a range of cytokines and chemokines were also examined in the air-pouch exudates, as well as
in vitro in epithelial colon cancer cells. Finally, the expression of specific TLRs was also studied
in time-course experiments, and a preliminary investigation of the downstream signaling pathway
involved was performed.
2. Materials and Methods
2.1. Cell Culture
Human colorectal adenocarcinoma cell line Caco-2 was purchased from the American Type
Culture Collection (ATCC). Cells were cultured in Dulbecco’s Modified Eagle Medium: Nutrient
Mixture F12 (DMEM-F12) with L-alanyl L-glutamine stable glutamine and was enriched with 10% fetal
bovine serum (FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin (all from Biosera, Boussens,
France). Caco-2 cultures were maintained at 37 ◦C, 5% CO2, in a humidified atmosphere, under sterile
conditions. Cells were seeded in plastic 100 mm plates, at a density of 2 × 106 cells.
2.2. Bacterial Strains and Culture Conditions
L. paracasei K5 was isolated from feta-type cheese [12]; L. casei ATCC 393 and L. rhamnosus
GG ATCC 53103 were obtained from the German Collection of Microorganisms and Cell Cultures
GmbH (DSMZ) (Braunschweig, Germany). All LAB strains were cultured in De Man, Rogosa,
and Sharpe (MRS) broth (Merck, Darmstadt, Germany), in anaerobic conditions, at 37 ◦C,
for 24 h. The bacterial cells were harvested by centrifugation (2.600 g/15 min) at stationary phase,
washed twice with sterile phosphate-buffered saline (PBS) buffer (Biosera, Boussens, France),
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and adjusted to the appropriate density in DMEM-F12 medium containing 10% FBS 20 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (all from Biosera, Boussens, France),
for the in vitro experiments, or in sterile PBS for the in vivo experiments.
2.3. Animals
Six- to 8-week-old BALB/c male mice, weighing about 20–25 g, were bred in the Animal House unit
of the Laboratory of Experimental Surgery and Surgical Research, Department of Medicine, Democritus
University of Thrace. They were housed in polycarbonate cages, under controlled environmental
conditions (20–23 ◦C, 12 h photoperiod), and had free access to tap water and standard commercial
pelleted diet (certified rat chow, VIOZOIS S.A., Thessaloniki, Greece). The experimental protocol,
as described below, in Section 2.4, was approved by the Animal Care and Use Committee of our
Institution (license number 1089/02-02-2016), in accordance with the requirements set by PD 56/2013,
which complied with Directive 2010/63/EU regarding protection of animals used for scientific purposes.
Each group included in the present study consisted of five animals, and each experiment was conducted
twice. Mice were euthanized after the experiment, by cervical dislocation.
2.4. Air-Pouch Formation and Exudate Collection
Air pouches were formed on the back of mice, as previously described [17] by subcutaneous
injection of 3 mL sterile air (day 0), followed by injections in a day-by-day basis (days 2 and 4), for the
formation of an equal size air pouch in each mouse (Figure 1A). On day 6, 5×108 cfu of L. paracasei K5,
L. casei ATCC 393, or L. rhamnosus GG resuspended in 200 µL sterile PBS was injected in dorsal air
pouches, while 200 µL of sterile PBS was injected in the air pouch of control animals. Three hours
post-injection, the exudates were collected by injecting 2 mL sterile PBS, followed by air-pouch lavage.
The samples were centrifuged at 2.600× g for 15 min. The supernatants were collected, filtered through
0.22 µm filters, and used for the detection of cytokines and chemokines, while the cell pellets were
examined for the presence of infiltrated leukocytes. The leukocyte populations were assessed by using
a hemocytometer and trypan blue exclusion assay.Microorganisms 2020, 8, x FOR PEER REVIEW 4 of 15 
 
 
Figure 1. Evaluation of the immunomodulatory effect of Lactobacillus paracasei K5, using the mouse 
air-pouch model. L. casei ATCC 393 and L. rhamnosus GG were also tested as reference strains. (A) 
Schematic representation of the mouse dorsal-air-pouch model. Control animals received only PBS. 
(B) Total number of the infiltrated leukocytes in the exudates of air pouches. L. paracasei K5, as well 
as probiotic strains L. casei ATCC 393 and L. rhamnosus GG, was injected in the air pouches raised in 
wild-type BALB/c mice. The data shown are the mean of 5 mice per group ± standard deviation. * 
Significantly different from animals that received L. paracasei K5 (p < 0.05). 
2.5. Detection of Cytokines and Chemokines in the Air-Pouch Exudates  
For the detection of cytokines and chemokines in the air-pouch exudates, the Proteome Profiler 
Mouse Cytokine Array kit (R&D Systems Inc., Minneapolis, MN, USA) was used by following the 
manufacturer’s protocol. Briefly, the filtered supernatants were mixed with a cocktail of 40 different 
biotinylated detection antibodies. The mixture was then incubated with the Mouse Cytokine Array 
membrane, overnight, at 4 °C. Following washing to remove unbound material, the membranes were 
incubated with Streptavidin-HRP (R&D Systems Inc., Minneapolis, MN, USA) for 30 min, at room 
temperature, and washed again, followed by chemiluminescence detection.  
2.6. Treatment of Caco-2 Cells with Probiotic Bacteria  
Caco-2 cells (2×106 cells/plate) were co-cultured with L. paracasei K5 (108 cfu) or L. rhamnosus GG 
(108 cfu) for the indicated timepoints (0, 2, 4, 8, 12, and 16 h), in DMEM-F12 medium containing 10% 
FBS and 20 mM HEPES, and were maintained at 37 °C, 5% CO2, in a humidified atmosphere, under 
sterile conditions. After the incubation period, the bacteria were removed by aspiration, the cells were 
washed twice with PBS, and then they were collected for RNA extraction. Control cells were 
maintained at the same conditions in DMEM-F12 medium containing 10% FBS and 20 mM HEPES. 
2.7. RNA Extraction and cDNA Synthesis 
Total RNA from Caco-2 cells was extracted, using RNAiso Plus (Takara, Saint-Germain-en-Laye, 
France), following manufacturer’s instructions. The concentration and purity of the extracted RNA 
were evaluated spectrophotometrically and by agarose gel electrophoresis. Then, cDNA was 
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Figure 1. Evaluation of the immunomodulatory effect of Lactobacillus paracasei K5, using the mouse
air-pouch model. L. casei ATCC 393 and L. rhamnosus GG were also tested as reference strains.
(A) Schematic representation of the mouse dorsal-air-pouch model. Control animals received only PBS.
(B) Total number of the infiltrated leukocytes in the exudates of air pouches. L. paracasei K5, as well
as probiotic strains L. casei ATCC 393 and L. rhamnosus GG, was injected in the air pouches raised
in wild-type BALB/c mice. The data shown are the mean of 5 mice per group ± standard deviation.
* Significantly different from animals that received L. paracasei K5 (p < 0.05).
2.5. Detection of Cytokines and Chemokines in the Air-Pouch Exudates
For the detection of cytokines and chemokines in the air-pouch exudates, the Proteome Profiler
Mouse Cytokine Array kit (R&D Systems Inc., Minneapolis, MN, USA) was used by following the
manufacturer’s protocol. Briefly, the filtered supernatants were mixed with a cocktail of 40 different
biotinylated detection antibodies. The mixture was then incubated with the Mouse Cytokine Array
membrane, overnight, at 4 ◦C. Following washing to remove unbound material, the membranes were
incubated with Streptavidin-HRP (R&D Systems Inc., Minneapolis, MN, USA) for 30 min, at room
temperature, and washed again, followed by chemiluminescence detection.
2.6. Treatment of Caco-2 Cells with Probiotic Bacteria
Caco-2 cells (2×106 cells/plate) were co-cultured with L. paracasei K5 (108 cfu) or L. rhamnosus GG
(108 cfu) for the indicated timepoints (0, 2, 4, 8, 12, and 16 h), in DMEM-F12 medium containing 10%
FBS and 20 mM HEPES, and were maintained at 37 ◦C, 5% CO2, in a humidified atmosphere, under
sterile conditions. After the incubation period, the bacteria were removed by aspiration, the cells
were washed twice with PBS, and then they were collected for RNA extraction. Control cells were
maintained at the same conditions in DMEM-F12 medium containing 10% FBS and 20 mM HEPES.
2.7. RNA Extraction and cDNA Synthesis
Total RNA from Caco-2 cells was extracted, using RNAiso Plus (Takara, Saint-Germain-en-Laye,
France), following manufacturer’s instructions. The concentration and purity of the extracted
RNA were evaluated spectrophotometrically and by agarose gel electrophoresis. Then, cDNA was
synthesized from 4 µg total RNA, by using PrimeScript 1st Strand cDNA Synthesis Kit (Takara,
Saint-Germain-en-Laye, France), following the manufacturer’s protocol.
2.8. Real Time PCR
Real-time PCR was performed using by the KAPA SYBR®FAST qPCR Kit (Kapa Biosystems,
Wilmington, MA, USA), according to manufacturer’s instructions. Each reaction mixture consisted
of a 20 µL total volume solution containing 10 µL SYBR Premix, 0.4 µL of forward and reverse
primer, 2 µL cDNA, and 7.2 µL ddH2O. The reactions were performed on a StepOne PCR System in
MicroAmp®Fast Optical 48-Well Reaction Plates (both from ThermoFisher Scientific, Loughborough,
UK), at the following conditions: 95 ◦C for 3 min, followed by 40 cycles of 95 ◦C for 15 sec and 60 ◦C for
1 min. The housekeeping gene b-actin served as an endogenous control. Each reaction was performed
in duplicates, and each experiment included two non-template controls. The sequences of the primers
used in the PCR are shown in Supplementary Materials Table S1. Primer specificity was verified by
performing a melting curve analysis. For the relative quantification of gene expression, the formula
RQ=2-∆∆Ct was used.
2.9. Statistical Analysis
GraphPad Prism (La Jolla, CA, USA) was used for statistical analysis of the data and construction of
graphs. Results are represented as the mean ± standard deviation. Statistical differences were analyzed
by 2-tailed Student’s t-tests. A p-value < 0.05 was considered statistically significant. Each in vitro
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experiment was replicated three independent times. For the in vivo experiments, each group consisted
of five animals, and each experiment was conducted twice.
3. Results and Discussion
3.1. L. paracasei K5 Triggered the Infiltration of Leukocytes and the Expression of Cytokines and Chemokines in
the Exudates of the Air Pouches
The immunomodulatory potential of L. paracasei K5 was initially investigated in vivo by employing
the dorsal-air-pouch mouse model. The commercially available probiotic strains L. casei ATCC 393 and
L. rhamnosus GG were utilized as reference. To this end, 5 × 108 cfu of L. paracasei K5 were injected in
the air pouches raised in wild-type BALB/c mice after six days (Figure 1A). As shown in Figure 1B,
the injection of L. paracasei K5 induced a rapid and strong recruitment of leukocytes in the exudates of
air pouches, significantly higher than L. casei ATCC 393 and L. rhamnosus GG (p < 0.05). Specifically,
the administration of L. paracasei K5 increased the infiltration of leukocytes in the exudates by eight-fold
compared to control mice that received only the PBS solution, whereas the administration of L. casei
ATCC 393 and L. rhamnosus GG enhanced the recruitment of leukocytes up to six-fold compared to the
control, as recorded before [18].
To further characterize the immunomodulatory effects of L. paracasei K5, the exudates of dorsal air
pouches were analyzed for the presence of cytokines and chemokines, by utilizing antibody arrays that
permit the simultaneous detection and semi-quantitative analysis of 40 different cytokines/chemokines
(Figure 2). The administration of L. paracasei K5 led to the differential expression of several cytokines and
chemokines in the air-pouch exudates compared to mice that received only the PBS solution (Figure 2).
In particular, L. paracasei K5 induced in the air-pouch exudates had higher levels of granulocyte-colony
stimulating factor (G-CSF); interleukins IL-1α, IL-1β, IL-1ra, IL- 6, and IL-16; and chemokines CCL3,
CCL4, CXCL1, and CXCL2, compared to the exudates from control mice that received only PBS.
Moreover, the administration of L. paracasei K5 caused decreased expression levels of sICAM, TIMP-1,
complement component 5α (C5α), macrophage colony-stimulating factor (M-CSF), and triggering
receptor expressed on myeloid cells 1 (TREM-1) (Figure 2D). The cytokines and chemokines with
differential expression are shown encircled in Figure 2C. The results of this semi-quantitative analysis
are summarized in Table 1.
Distinct modulation of the immune response in vivo following probiotic administration has been
well documented. For example, we have showed previously that administration of L. pentosus B281
and L. plantarum B282, two recently characterized probiotic strains, induced significant recruitment
of leukocytes in the air-pouch exudates of mice and differential expression of specific cytokines and
chemokines [18]. Similarly, the probiotic strain Lactobacillus casei BL23 promoted a Th17-biased immune
response, followed by the expression of proinflammatory cytokines (IL-6, IL-17, IL-10, and TGF-β),
in a mouse model of intestinal inflammation [19]. Moreover, it has recently been demonstrated that
oral treatment of BALB/c mice with the probiotic strain L. fermentum UCO-979C caused a significant
increase in the production of interferon-γ (IFN-γ) and IL-6, as well as the stimulation of intestinal and
peritoneal macrophages and the maturation of B cells [20].
Importantly, the infiltration of immune cells promoted by probiotic administration has been linked
to beneficial health effects to the host. Indeed, it has been showed recently that the preemptive per
os administration of L. casei ATCC 393 to colon CT26 syngeneic tumor mice model led to changes
in the tumor microenvironment, which favored Th1 immunological responses and the recruitment
of CD3+CD8+ cytotoxic T cells. More specifically, the production of granzyme B, TNF-α, and IL-12
was enhanced, promoting the maturation and migration of CD3+CD8+ cytotoxic T cells, leading to an
almost four-fold increase of their population, in situ. These changes were correlated with a significant
reduction in tumor volume, compared to control [21]. Likewise, Hu et al. used the same experimental
model and showed that the per os administration of L. plantarum for 14 days enhanced CD8+ T and
natural killer (NK) cells recruitment, leading to survival prolongation of the tumor-bearing mice [22].
Importantly, probiotics that modulate the recruitment of immunological populations to the tumor site
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could be used in combination with other immunotherapy drugs. Such an approach could aid clinicians
in the treatment of chemo-resistant cancers. In this context, administration of the probiotic strain
Escherichia coli strain Nissle 1917 to 4T1- and H22-subcutaneous-tumor-bearing BALB/c mice caused
increased infiltration of CD3+CD8+ cytotoxic T cells. However, co-administration with galunisertib,
a tumor growth factor beta (TGF-β) blockade agent, induced a more pronounced effect, as it enhanced
the recruitment of dendritic cells and antigen-specific IFN-γ+CD8+ T cells within the tumor and in
tumor-draining lymph nodes [23]. Clearly, this niche of probiotic research is very promising, but more
studies should be conducted before the introduction of such practices in the clinic.Microorganisms 2020, 8, x FOR PEER REVIEW 6 of 15 
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K5 (A) or PBS (B) were administered in the air pouches of BALB/c mice, and after three hours, the 
exudates were collected, and the supernatants were analyzed for cytokine/chemokine expression, 
using the Proteome Profiler TM Mouse Antibody Array Panel A. The cytokines and chemokines with 
differential expression are encircled in red (C). The positions of the anti-cytokine and anti-chemokine 
antibodies (in duplicates) on the membranes are also indicated. The pairs of spots in the upper-left, 
upper-right, and lower-left corners are positive controls. (D) Data from (A,B) were quantified as mean 
pixel density normalized to the density of the positive controls. The use of two replicates per analyte 
limits the application of robust statistics. 
Table 1. Differential expression of cytokines, chemokines, and other inflammatory markers, as a result 
of air-pouch exposure to L. paracasei K5. 
Markers L. paracasei K5 
IL-1α  ↑a 
IL-1β ↑ 
IL-1rα ↑ 
IL-16 ↑ 
IL-6 ↑ 
C5a ↓ 
CCL2 ndb 
CCL3 ↑ 
CCL4 ↑ 
CCL12  ↓c 
IFN-γ nd 
sICAM-1 ↓ 
CXCL1 ↑ 
CXCL2 ↑ 
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Table 1. Differential expression of cytokines, chemokines, and other inflammatory markers, as a result
of air-pouch exposure to L. paracasei K5.
Markers L. paracasei K5
IL-1α ↑ a
IL-1β ↑
IL-1rα ↑
IL-16 ↑
IL-6 ↑
C5a ↓
CCL2 nd b
CCL3 ↑
CCL4 ↑
CCL12 ↓ c
IFN-γ nd
sICAM-1 ↓
CXCL1 ↑
CXCL2 ↑
CXCL12 ↓
CXCL13 ↓
G-CSF ↑
M-CSF ↓
TIMP-1 ↓
TREM-1 ↓
a Upregulation; b no detection; c downregulation.
3.2. Induction of Cytokine and Chemokine Expression in Caco-2 cells upon Treatment with L. paracasei K5
Although the mouse air-pouch system has been well established for studying the
immunostimulatory effects of probiotic bacteria, it has been reported that the immune responses may
vary in the air pouch and the gut intestine for certain probiotic strains [24]. In this vein, we studied the
impact of the L. paracasei K5 on human colon cancer cells Caco-2, an in vitro system that simulates
the intestinal epithelium. More specifically, the expression levels of the chemokine CXCL2, of the
inflammation markers sICAM and TIMP-1 (Figure 3), as well as of the cytokines IL-1α, IL-1β, IL-6 and
TNF-α (Figure 4), were investigated by qPCR upon treatment of Caco-2 cells with L. paracasei K5 in
time-course experiments. The results showed that L. paracasei K5 treatments induced a time-dependent
upregulation of the expression of CXCL-2, sICAM-1, and TIMP-1 (Figure 3A,C,E). All three markers
peaked 12 h posttreatment, in a statistically significant manner, and returned to basal levels at 16 h.
Treatment with the reference probiotic strain L. rhamnosus GG induced similar effects on the expression
levels of the above genes. In particular, the maximum expression levels of CXCL-2 were observed 12 h
posttreatment (Figure 3B) and of sICAM-1 and TIMP-1 were observed 10 h posttreatment (Figure 3D,F).
After the 16-h mark, the expression levels of CXCL-2 and sICAM-1 returned to the basal state, while
the levels of TIMP-1 reached a lower value (p < 0.01) (Figure 3F). Interestingly, the levels of sICAM and
TIMP-1 were decreased in the air-pouch exudates, following L. paracasei K5 administration (Figure 2D).
This difference could be attributed to the fact that a heterogenous cell population constitutes the air
pouch and each cell type might respond differently to the probiotic strain rather than the uniform
Caco-2 monolayer. The pro-inflammatory mediators IL-1α, IL-1β, IL-6, and TNF-α also showed a
time-dependent increase in their relative expression levels that was counteracted after 16 h of treatments
with either L. paracasei K5 or L. rhamnosus GG (Figure 4). More specifically, the expression of IL-1α,
IL-6, and TNF-α peaked at 12 h posttreatment, while the expression of IL-1β reached its highest levels
after 10 h of treatment. Of note, while the expression levels of IL-1α, IL-1β, and IL-6 returned to basal
levels after 16 h, the increased expression of TNF-α persisted (Figure 4G,H).
These findings demonstrated that L. paracasei K5 induced an innate immune response through the
time-regulated overexpression of specific pro-inflammatory cytokines and chemokines. In this line,
it was demonstrated that treatment of intestinal epithelial cells with L. acidophilus NCFM enhanced
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the expression levels of the pro-inflammatory cytokines IL-1α and IL-1β and the chemokines CCL2
and CCL20, in a time-dependent manner [25]. Similarly, a transient overexpression of IL-1β, IL-6,
and TNF-α was recorded in the Caco-2 cells stimulated by the probiotic strain Lactobacillus plantarum
NDC 75017 [26]. In the same context, Caco-2 cells treated with L. gasseri CMUL34, L. acidophilus
CMUL67, L. gasseri CMUL80, L. gasseri CMUL99, or L. plantarum CMUL140 showed a significant
upregulation of IL-6 [27].
It is evident that probiotic bacteria can regulate host immune responses through the
induction of a range of mediators from intestinal epithelial cells. However, supplementation with
probiotics that induce pro-inflammatory effects could exacerbate immune responses in patients with
inflammation-related disorders, such as inflammatory bowel disease (IBD), ultimately leading to
unfavorable outcomes [28]. Therefore, characterization of the bioactive molecules of probiotics and
elucidation of their mechanisms of action should be performed to confirm their beneficial effects on the
host [29].
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Figure 3. Expression levels of CXCL-2, sICAM-1, and TIMP-1 mRNA in Caco-2 cancer cell line induced
by Lactobacillus paracasei K5 and L. rhamnosus GG. Cells were stimulated with L. paracasei K5 (A,C,E) or
L. rhamnosus GG (B,D,F) in different time points (0, 2, 4, 8, 10, 12, and 16 h), and the relative expression
of these genes was determined by qPCR. Control cells were treated only with DMEM F-12. The data
presented are the mean ± standard deviation of three independent experiments. * p < 0.05; ** p < 0.01
compared to control.
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3.3. L. paracasei K5 Induced the Transient Expression of TLRs in Caco-2 Cells
Probiotic bacteria could evoke immune responses by interacting with extracellular and intracellular
TLRs. In this vein, Caco-2 cells were treated with 108 cfu of L. paracasei K5 in time-course experiments,
and the expression levels of TLR-2, TLR-4, TLR-6, and TLR-9 were analyzed at the transcriptional
level, using qPCR. The data showed a rapid but transient upregulation of the genes coding for TLRs
following L. paracasei K5 treatments. More specifically, TLR-2 was strongly upregulated at two hours
posttreatment, and then sharply declined to basal levels (Figure 5A). The maximum expression levels
of TLR-4 and TLR-6 were observed at four hours posttreatment; however, they decreased to sub-basal
levels at 12 h (p < 0.05) (Figure 5B,C). Of note, the expression pattern of TLR-9 after the stimulations
was characterized by two peaks at four hours (p < 0.01) and at 12 h (p < 0.05). The expression levels of
this gene returned to the basal state by the 16-h mark (Figure 5D).
TLRs represent a receptor family employed by the innate immune system to recognize microbe- or
host-specific antigens, called pathogen-associated molecular patterns (PAMPs) or damage-associated
molecular patterns (DAMPs), respectively. It is well documented that many probiotic strains can
orchestrate immune responses by modulating the expression of TLRs. Indeed, the probiotic strains
L. acidophilus NCFM and L. plantarum NDC 75017 significantly upregulated the expression of TLR-2 in
Caco-2 cells by stimulating the NF-κB and p38 MAPK signaling pathways, as shown in two independent
studies [25,26]. In a similar manner, L. rhamnosus GG and L. plantarum BFE 1685 significantly elevated
the transcriptional levels of TLR-2, TLR-5, and TLR-9 in HT-29 colon cancer cells [30]. The expression
of TLR-9 was also upregulated after treatments of Caco-2 cells with cell-free supernatants or isolated
nucleic acids of L. johnsonii N6.2. Such events led to the production of type 1 interferons, mimicking
a low-grade viral infection, with potential prophylactic effects [31]. In the same context, two-hour
treatments of HT-29 cells with the probiotic strain L. johnsonii BFE 6128 stimulated the expression
of TLR-2, TLR-5, TLR-7, and TLR-9 and the simultaneous activation of the transcription factors
interferon regulatory factor 1 (IRF), nuclear factor of light polypeptide gene enhancer in B cells
2 (NFKB2), and V-fos FBJ murine osteosarcoma viral oncogene homologue (FOS) [32]. Finally, it
has been well documented that LAB strains may induce distinct inflammatory responses via the
interaction with TLR-2 and TLR-4. For example, it has been shown that the interaction of L. delbrueckii
subsp. delbrueckii TUA4408L and its extracellular polysaccharide (EPS), with TLR-2 and TLR-4,
modulated the inflammatory response of porcine intestinal epithelial (PIE) cells against enterotoxigenic
E. coli [33]. Similarly, L. plantarum N14 and its exopolysaccharide attenuated the production of specific
pro-inflammatory cytokines from PIE cells, in response to enterotoxigenic Escherichia coli challenge, via
TLR-2 and TLR-4 [34].
Finally, to initially characterize the downstream signaling pathways involved in the observed
immunostimulatory activity of L. paracasei K5, Caco-2 cells were pretreated for one hour, either with a
p38 MAPK specific inhibitor, SB203580, or with a vehicle stimulated with L. paracasei K5, and then the
expression levels of the pro-inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α were monitored
by qPCR. Inhibition of the p38 MAPK pathway by SB203580 resulted in a significant decrease in the
expression of IL-1α, IL-1β, IL-6, and TNF-α, 12 h post L. paracasei K5 administration (Supplementary
Figure S1). Notably, previous studies from our team have shown that L. paracasei K5 may have direct
anti-proliferative effects on Caco-2 cells by inducing apoptosis [16]. Evidently, it would be of particular
interest to explore further the signaling pathways associated with the molecular mechanisms of action
of L. paracasei K5, to elucidate and establish its probiotic character.
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Figure 5. Expression levels of (A) TLR-2, (B) TLR-4, (C) TLR-6, and (D) TLR-9 mRNA in the Caco-2
colon adenocarcinoma cell line upon L. paracasei K5 stimulation in different time points (0, 2, 4, 8, 10,
12, and 16 h), as determined by qPCR. Control cells were treated only with DMEM F-12. The data
presented are the mean ± standard deviation of three independent experiments. * p < 0.05; ** p < 0.01
compared to control.
4. Conclusions
In the present study, we investigated the immunomodulatory potential of L. paracasei K5, in vitro
and in vivo, to further support its probiotic character. Delineating the immunomodulatory potential
of probiotics is of great importance for the deter ination of their safety. Indeed, administration of
probiotics that exhibit high immunostimulatory effects should potentially be avoide for consumers
with chronic inflammation. In this context, the guidelines for the evaluation of probiotics in food
issued by FAO/WHO clearly state that human trials should also be performed, to vali ate the safety
and efficacy of probiotics prior to their application in the food industry [1].
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Conclusively, our results showed that the injection of L. paracasei K5 to dorsal air pouches of
BALB/c mice caused the enhanced recruitment of leukocytes on site (eight-fold), compared to mice that
received sterile PBS. Analysis of the exudates revealed elevated levels of various pro-inflammatory
factors and chemokines. The immunomodulatory effects of this strain were further confirmed in vitro,
in time-course experiments. Indeed, treatment with L. paracasei K5 induced transient changes in the
expression of the pro-inflammatory mediators IL-1α, IL-1β, IL-6, TNF-α, CXCL2, sICAM, and TIMP-1.
Concomitantly, rapid upregulation of the expression of TLRs was demonstrated. Indeed, the levels
of TLR-2, TLR-4, and TLR-6 were sharply elevated in less than four hours, while the levels of TLR-9
remained high throughout the time course, before reaching basal levels at 16 h. Lastly, preliminary
experiments with a p38 MAPK inhibitor indicated a possible involvement of the p38 MAPK pathway
in L. paracasei K5 immunostimulatory action. More studies are required to fully understand the cellular
processes that take place upon stimulation with L. paracasei K5.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/8/5/709/s1.
Figure S1: Percentage of the reduction of the relative expression of genes encoding IL-1α, IL-1β, IL-6, and TNF-α
in Caco-2 cells pretreated with the inhibitor SB203580 (p38 inhibitor) or vehicle and then cultured with L. paracasei
K5 for 12 h. Table S1: The primers used at the quantitative real-time PCR analysis.
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